Novitium Pharma LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 16, 2024
  • No warning letters matched by name
Inspections 5 0 OAI
Recalls 6 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Novitium Pharma LLC has 6 FDA recalls, 5 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Novitium Pharma LLC" is on file.

What these totals cover: FDA records filed under the name "Novitium Pharma LLC" and its spelling variant "Novitium Pharma".

Latest recall
D-0443-2024 · Class III · Mar 25, 2024
Latest inspection
Feb 16, 2024 · NAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls6Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections5Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Novitium Pharma LLC's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Novitium Pharma LLC: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202410020
202310000
202200000
202110000
202000000
201910040
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Novitium Pharma LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novitium Pharma LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

6 recall records from Oct 25, 2019 to Mar 25, 2024.

NumberClassProductDate
D-0443-2024Class IIIDigoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium…Mar 25, 2024
D-0389-2024Class IIIDigoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium…Mar 4, 2024
D-0310-2020Class IINovitium Pharma Ranitidine Capsules 150 mg 60 capsules Rx Only Manufactured by: Novitium Pharma LLC…Oct 25, 2019
D-0311-2020Class IINovitium Pharma Ranitidine Capsules 150 mg 500 capsules Rx Only Manufactured by: Novitium Pharma LLC…Oct 25, 2019
D-0313-2020Class IINovitium Pharma Ranitidine Capsules 300 mg 100 capsules Rx Only Manufactured by: Novitium Pharma LLC…Oct 25, 2019
D-0312-2020Class IINovitium Pharma Ranitidine Capsules 300 mg 30 capsules Rx Only Manufactured by: Novitium Pharma LLC…Oct 25, 2019

Recent FDA inspections

5 inspections from May 9, 2018 to Feb 16, 2024.

DateSiteProductClassificationFEI
Feb 16, 2024East Windsor, NJDrugsNo Action Indicated (NAI)3012541241
Mar 31, 2023East Windsor, NJDrugsNo Action Indicated (NAI)3012541241
Jul 8, 2021East Windsor, NJDrugsNo Action Indicated (NAI)3012541241
Feb 4, 2019East Windsor, NJDrugsVoluntary Action Indicated (VAI)3012541241
May 9, 2018East Windsor, NJDrugsNo Action Indicated (NAI)3012541241
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3012541241East Windsor, NJ5Feb 16, 2024

Novitium Pharma LLC and the FDA: common questions

Has Novitium Pharma LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Novitium Pharma LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Novitium Pharma LLC received an FDA Form 483?

FDA has not published a Form 483 for "Novitium Pharma LLC" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Novitium Pharma LLC?

The most recent FDA inspection on file ended Feb 16, 2024 at East Windsor, NJ and was classified NAI. FDA has 5 inspections of Novitium Pharma LLC on file.

Has Novitium Pharma LLC had an FDA recall?

Yes. Novitium Pharma LLC has 6 FDA recalls on record. The most recent started Mar 25, 2024.

Need more than this page shows? Ask about Novitium Pharma LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.